Gadolinium-based Contrast Agents Current Events | Gadolinium-based Contrast Agents News
|
| Page
1 of
23 |
449 Results |
|
|
|
Sort By:
Page Views | Date |
Even at High Doses, Gadolinium-Based Contrast Agents Cannot by Themselves Cause Patients to Develop Nephrogenic Systemic Fibrosis
Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems. view more (2009-07-01)
Allergic reactions to gadolinium-based contrast agents are rare, study finds
Allergic-like reactions to gadolinium-containing contrast injections in adults and pediatric patients (those younger than 19 years of age) are rare, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor. view more (2007-12-28)
Allergic-like reactions occur in premedicated patients
Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor. view more (2008-02-11)
MRI contrast agent linked to rare disease
New research has shown a possible association between a popular magnetic resonance imaging (MRI) contrast agent and the incidence of a rare disease called nephrogenic systemic fibrosis (NSF) in patients with kidney disease. view more (2007-01-29)
Gadonanotubes greatly outperform existing MRI contrast agents
Researchers at Rice University, the Baylor College of Medicine, the University of Houston and the Ecole Polytechnique Fédérale de Lausanne in Switzerland have created a new class of magnetic resonance imaging (MRI) contrast agents that are at least 40 times more effective than the best in clinical use. view more (2005-08-12)
Despite ongoing safety concerns, study finds adverse reactions from contrast agents rarely occur
Iodinated and Gadolinium based contrast agents, frequently used during computed tomography (CT) and MRI scans to aid in the imaging process, are associated with a very low rate of adverse effects, according to a large cohort study published in the October issue of the American Journal of Roentgenology (AJR). view more (2009-09-21)
Painful condition affecting kidney failure patients increases risk of death
A painful and debilitating condition that affects patients with kidney failure may be more common than previously believed and appears to be strongly associated with prior exposure to certain contrast agents used in imaging studies. view more (2007-09-28)
New contrast agents may be on horizon for better medical imaging
Research by scientists based at the University of Illinois at Urbana-Champaign may lead to the development of a new breed of "multimodal" contrast agents that could work within a host of medical imaging platforms — from ultrasound and computed tomography (CT) to magnetic resonance imaging and molecular imaging. view more (2006-06-08)
Newer contrast agents safe for children
Allergic-like reactions to newer iodine-containing contrast agents (nonionic contrast media), are rare in children according to a recent study conducted by researchers from the University of Michigan Medical Center and C.S. Mott Children's Hospital both in Ann Arbor. view more (2007-06-08)
New study suggests cause of debilitating skin condition
New findings from researchers at Wake Forest University Baptist Medical Center and colleagues suggest why some people with kidney failure can develop a rare tightening and swelling of the skin and other organs, including the lungs and heart. view more (2007-09-25)
New disease-fighting nanoparticles look like miniature pastries
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques. view more (2008-07-30)
NYU researchers decorate virus particles, showing potential to enhance MRI capabilities
Researchers at New York University have made chemical modifications to nanometer sized virus particles—a process that has the potential to improve magnetic resonance imaging (MRI) techniques. Their results are reported in the latest issue of Nano Letters. view more (2006-06-14)
MRI better than MDCT in detecting endoleaks, study says
Contrast-enhanced MR imaging is significantly superior to 16 slice multidetector CT in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study conducted by researchers at Ospedale San Giovanni in Bellinzona, Switzerland. view more (2008-04-14)
New Generation of Contrast Agents Provides Hope for Enhanced Brain Tumor Diagnostics
In a pilot study of gadobenate dimeglumine (GD-BOPTA), the new contrast agent has yielded improved diagnostic imaging of brain tumors in magnetic resonance imaging (MRI) compared to standard contrast media. A team of researchers headed by PD Dr. Marco Essig, Division of Radiology of the Deutsches Krebsforschungszentrum (German Cancer Research... view more... (2004-05-03)
Study: Before a CT scan or angiogram, many people should take inexpensive drug to protect kidneys
As more and more Americans undergo CT scans and other medical imaging scans involving intense X-rays, a new study suggests that many of them should take a pre-scan drug that could protect their kidneys from damage. view more (2008-02-19)
Getting better visualization of joint cartilage through cationic CT contrast agents
In its quest to find new strategies to treat osteoarthritis and other diseases, a Boston University-led research team has reported finding a new computer tomography contrast agent for visualizing the special distributions of glycosaminoglycans (GAGs) - the anionic sugars that account for the strength of joint cartilage. view more (2009-09-02)
Radiotherapy advance points way to noninvasive brain cancer treatment
With an equal rate of incidence and mortality-the number of those who get it, and the number of those who die from it-Glioblastoma Multiforme (GBM) is a brain cancer death sentence. view more (2006-01-03)
New Research Shows Benefits of Ultrasound Contrast Agents Outweigh Potential Risk to Heart Patients
ST. LOUIS - A Saint Louis University cardiologist called upon the U.S. Food and Drug Administration (FDA) on Monday to reconsider a strong warning it recently placed on a diagnostic tool, stating that the warning could prevent doctors from detecting life-threatening cardiac events. view more (2008-04-01)
Cancer drug extends cognitive function in patients with brain metastases
he drug Xcytrin®, based on a molecule developed by chemists at The University of Texas at Austin, shows significant promise in prolonging cognitive function in patients with non-small cell lung cancer that has metastasized to the brain. view more (2006-06-06)
Using nano-magnets to enhance medical imaging
Nanoscale magnets in the form of iron-containing molecules might be used to improve the contrast between healthy and diseased tissue in magnetic resonance imaging (MRI)—as long as the concentration of nanomagnets is carefully managed. view more (2007-02-02)
|
|
| Page
1 of
23 |
449 Results |
|
|
|
Sort By:
Page Views | Date |
|
